Cargando…

Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases

Since the seminal breakthrough of treating diabetic patients with insulin in the 1920s, there has been great interest in developing other proteins and their peptide mimetics as therapies for a wide variety of other medical disorders. Currently, there are at least 60 different peptides that have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolska, Anna, Reimund, Mart, Sviridov, Denis O., Amar, Marcelo J., Remaley, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000854/ https://www.ncbi.nlm.nih.gov/pubmed/33800446 http://dx.doi.org/10.3390/cells10030597

Ejemplares similares

Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
por: Sviridov, Denis, et al.
Publicado: (2023)

Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice
por: Komatsu, Tomohiro, et al.
Publicado: (2019)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux
por: Islam, Rafique M., et al.
Publicado: (2018)

An Apolipoprotein A-I Mimetic Peptide Designed with a Reductionist Approach Stimulates Reverse Cholesterol Transport and Reduces Atherosclerosis in Mice
por: Ditiatkovski, Michael, et al.
Publicado: (2013)

Complex association of apolipoprotein E–containing HDL with coronary artery disease burden in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2022)

Structural flexibility of apolipoprotein E-derived arginine-rich peptides improves their cell penetration capability
por: Takechi-Haraya, Yuki, et al.
Publicado: (2023)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

Apolipoprotein E mimetic peptide protects against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2014)

A New Structural Model of Apolipoprotein B100 Based on Computational Modeling and Cross Linking
por: Jeiran, Kianoush, et al.
Publicado: (2022)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke
por: Tu, Tian Ming, et al.
Publicado: (2017)

Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
por: Marinho, Aline T., et al.
Publicado: (2019)

Apolipoprotein E mimetic peptide COG1410 combats pandrug-resistant Acinetobacter baumannii
por: Wang, Bo, et al.
Publicado: (2022)

Development of an apolipoprotein E mimetic peptide–lipid conjugate for efficient brain delivery of liposomes
por: Kato, Naoya, et al.
Publicado: (2023)

Targeting Lipid Rafts—A Potential Therapy for COVID-19
por: Sviridov, Dmitri, et al.
Publicado: (2020)

The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
por: Di Bartolo, Belinda A, et al.
Publicado: (2011)

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis
por: Azevedo, Orleâncio Gomes R, et al.
Publicado: (2012)

Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH
por: Liu, Ji, et al.
Publicado: (2018)

Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010)

Erratum to: Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
por: Amar, Marcelo J. A., et al.
Publicado: (2017)

Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis
por: Sharifov, Oleg F., et al.
Publicado: (2013)

Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
por: Peng, Meiyu, et al.
Publicado: (2017)

Comparison of Mechanisms of Endothelial Cell Protections Between High-Density Lipoprotein and Apolipoprotein A-I Mimetic Peptide
por: Xu, Wenqi, et al.
Publicado: (2019)

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
por: Woo, Jennifer MP, et al.
Publicado: (2010)

Collagen Mimetic Peptides
por: Xu, Yujia, et al.
Publicado: (2021)

Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids
por: Giorgi, Laura, et al.
Publicado: (2022)

The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications
por: Ballout, Rami A., et al.
Publicado: (2020)

Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides
por: Montoliu-Gaya, Laia, et al.
Publicado: (2017)

Apolipoprotein E-Mimetic Peptide COG1410 Enhances Retinal Ganglion Cell Survival by Attenuating Inflammation and Apoptosis Following TONI
por: Kuai, Li, et al.
Publicado: (2019)

Apolipoprotein A-I mimetic peptides (ApoAI MP) improve oxidative stress and inflammatory responses in Parkinson’s disease mice
por: Jiang, Hongfang, et al.
Publicado: (2022)

Apolipoprotein E mimetic peptide COG1410 alleviates blood‑brain barrier injury in a rat model of ischemic stroke
por: Xue, Yunwen, et al.
Publicado: (2023)

The Apolipoprotein-AI Mimetic Peptide L4F at a Modest Dose Does Not Attenuate Weight Gain, Inflammation, or Atherosclerosis in LDLR-Null Mice
por: Averill, Michelle M., et al.
Publicado: (2014)

The apolipoprotein A‐I mimetic peptide, D‐4F, restrains neointimal formation through heme oxygenase‐1 up‐regulation
por: Liu, Donghui, et al.
Publicado: (2017)

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer
por: Peng, Meiyu, et al.
Publicado: (2020)

Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity
por: Fernandez-Sendin, Myriam, et al.
Publicado: (2021)

NMR-Based Metabolomic Analysis on the Protective Effects of Apolipoprotein A-I Mimetic Peptide against Contrast Media-Induced Endothelial Dysfunction
por: Jiang, Ting, et al.
Publicado: (2021)

Peptide and non‐peptide mimetics as potential therapeutics targeting oral bacteria and oral biofilms
por: Sztukowska, Maryta N., et al.
Publicado: (2019)

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1
por: He, Dan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1sa9a09ckj7mo1drk5nmhfstsc